UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 19, 2026
Sale
Calculated transaction value
$1.2M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 18, 2026
Public filing date
Aug 19, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$518.27
Aug 18, 2026
Close before public filing
$518.27
Aug 18, 2026
Return since public filing
-4.08%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,333 shares @ $514.99
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000123
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$6.18M
Buys / sales
0 / 10
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 18, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 18, 2026 | $121.77K |
| United Therapeutics Corp UTHR | Sale | Aug 18, 2026 | $117.92K |
| United Therapeutics Corp UTHR | Sale | Aug 18, 2026 | $86.97K |
| United Therapeutics Corp UTHR | Sale | Aug 18, 2026 | $225.23K |
| United Therapeutics Corp UTHR | Sale | Aug 18, 2026 | $649.92K |
| United Therapeutics Corp UTHR Current | Sale | Aug 18, 2026 | $1.2M |
| United Therapeutics Corp UTHR | Sale | Aug 18, 2026 | $970.16K |
| United Therapeutics Corp UTHR | Sale | Aug 18, 2026 | $451.42K |
| United Therapeutics Corp UTHR | Sale | Aug 18, 2026 | $844.64K |
| United Therapeutics Corp UTHR | Sale | Aug 18, 2026 | $228.72K |
| United Therapeutics Corp UTHR | Exercise | Aug 18, 2026 | $0 |